Applied Genetic Technologies Corp

-0.12 (-5.04%)
Earnings Announcements

AGTC Announces Financial Results And Business Update For The Quarter Ended September 30, 2021

Published: 11/09/2021 12:41 GMT
Applied Genetic Technologies Corp (AGTC) - Agtc Announces Financial Results and Business Update for the Quarter Ended September 30, 2021.
On Track to Provide Multiple Data Readouts for Xlrp and Achm Clinical Programs in 2021 and 2022.
Qtrly Net Loss per Common Share $0.40.
Believes Funds Will Be Sufficient to Currently Planned Research and Discovery Programs Into Calendar Year 2023.
Q1 Earnings per Share View $-0.35 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.